301 related articles for article (PubMed ID: 31023861)
1. Clinical Characteristics and Survival of Patients with Malignant Ovarian Tumors in Addis Ababa, Ethiopia.
Piszczan S; Desalegn D; Petros H; Gurmu M; Kroeber ES; Addissie A; Mikolajczyk R; Ghebre RG; Mathewos A; Thomssen C; Jemal A; Kantelhardt EJ
Oncologist; 2019 Jun; 24(6):e303-e311. PubMed ID: 31023861
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
Tang L; Zheng M; Xiong Y; Ding H; Liu FY
Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
[TBL] [Abstract][Full Text] [Related]
3. Treatment Approach and Prognosis of Pediatric and Adolescent Nonepithelial Malignant Ovarian Tumors: A Retrospective Prognosis Analysis.
Liang P; Zhang X; Zhang Z; Xu G; Yu X; Li S; Zhang Y; Bian L; Zhang B
J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):304-310. PubMed ID: 28993225
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Carlson JW; Ozols RF; Rose PG; Markman M; Armstrong DK; Muggia F; McGuire WP;
J Clin Oncol; 2007 Aug; 25(24):3621-7. PubMed ID: 17704411
[TBL] [Abstract][Full Text] [Related]
5. Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin.
Liu W; Qdaisat A; Soliman PT; Ramondetta L; Lopez G; Narayanan S; Zhou S; Cohen L; Bruera E; Yeung SJ
Oncologist; 2019 Jun; 24(6):e312-e317. PubMed ID: 30940743
[TBL] [Abstract][Full Text] [Related]
6. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Addis Ababa population-based pattern of cancer therapy, Ethiopia.
Feuchtner J; Mathewos A; Solomon A; Timotewos G; Aynalem A; Wondemagegnehu T; Gebremedhin A; Adugna F; Griesel M; Wienke A; Addissie A; Jemal A; Kantelhardt EJ
PLoS One; 2019; 14(9):e0219519. PubMed ID: 31536505
[TBL] [Abstract][Full Text] [Related]
9. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
[TBL] [Abstract][Full Text] [Related]
10. Treatment Outcomes of Epithelial Ovarian Cancers Following Maximum Cytoreduction and Adjuvant Paclitaxel-Carboplatin Chemotherapy: Egyptian NCI Experience.
Nassar HR; Zeeneldin AA; Helal AM; Ismail YM; Elsayed AM; Elbassuiony MA; Moneer MM
Asian Pac J Cancer Prev; 2015; 16(16):7237-42. PubMed ID: 26514517
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer survival in Ethiopia: a cohort study of 1,070 women.
Kantelhardt EJ; Zerche P; Mathewos A; Trocchi P; Addissie A; Aynalem A; Wondemagegnehu T; Ersumo T; Reeler A; Yonas B; Tinsae M; Gemechu T; Jemal A; Thomssen C; Stang A; Bogale S
Int J Cancer; 2014 Aug; 135(3):702-9. PubMed ID: 24375396
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with advanced stage at diagnosis of cervical cancer in Addis Ababa, Ethiopia: a population-based study.
Dereje N; Gebremariam A; Addissie A; Worku A; Assefa M; Abraha A; Tigeneh W; Kantelhardt EJ; Jemal A
BMJ Open; 2020 Oct; 10(10):e040645. PubMed ID: 33051237
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
15. Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Pectasides D; Papaxoinis G; Fountzilas G; Aravantinos G; Bamias A; Pavlidis N; Kalofonos HP; Timotheadou E; Samantas E; Briasoulis E; Skarlos DV; Economopoulos T; Dimopoulos MA;
Anticancer Res; 2009 Feb; 29(2):745-51. PubMed ID: 19331231
[TBL] [Abstract][Full Text] [Related]
16. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
Venesmaa P
Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
[TBL] [Abstract][Full Text] [Related]
17. Vulvar cancer in Ethiopia: A cohort study on the characteristics and survival of 86 patients.
Kroeber ES; Mathewos A; Wondemagegnehu T; Aynalem A; Gemechu T; Piszczan S; Timotewos G; Addissie A; Wienke A; Unverzagt S; Thomssen C; Jemal A; Kantelhardt EJ
Medicine (Baltimore); 2018 Mar; 97(9):e0041. PubMed ID: 29489654
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care and outcomes for women with uterine cancer and ovarian metastases.
Jones NL; Huang Y; Chatterjee S; Tergas AI; Burke WM; Hou JY; Deutsch I; Ananth CV; Neugut AI; Hershman DL; Wright JD
Int J Gynecol Cancer; 2019 Feb; 29(2):365-376. PubMed ID: 30718315
[TBL] [Abstract][Full Text] [Related]
19. Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?
Lydiksen L; Jensen-Fangel S; Blaakaer J
Gynecol Oncol; 2014 Jun; 133(3):454-9. PubMed ID: 24726613
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
